SCHEDULE OF FAIR VALUE OF ASSETS ACQUIRED AND LIABILITIES ASSUMED AT DATE OF ACQUISITION (Details) (Parenthetical) - USD ($) |
12 Months Ended | ||
|---|---|---|---|
Oct. 11, 2024 |
Dec. 31, 2025 |
Dec. 31, 2024 |
|
| Asset impairment charges | $ 29,511 | $ 1,771,891 | |
| Customer deposits | $ (572,386) | ||
| Renu Laboratories, Inc [Member] | |||
| Purchase price | 1,780,000 | ||
| Customer deposits | $ 572,386 | ||
| X | ||||||||||
- Definition Business combination recognized identifiable assets acquired and liabilities assumed current liabilities customer deposits. No definition available.
|
| X | ||||||||||
- Definition The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Details
|